| Emerging role of biosimilars in oncology-hematology in Saudi Arabia: a practical perspective MA Khan, MA Aseeri, MA Alshamrani, AH Alnatsheh, HS Alhamdan Global Journal on Quality and Safety in Healthcare 3 (1), 22-29, 2020 | 9 | 2020 |
| Comparison of the effectiveness of venous thromboembolism prophylaxis with enoxaparin between obese and non-obese patients AH Alnatsheh, RD Beckett, S Waterman Journal of Oncology Pharmacy Practice 25 (4), 813-817, 2019 | 6 | 2019 |
| Comparison of biosimilar filgrastim with innovator fligrastim for peripheral blood stem cells mobilization, collection of CD34+ stem cells, and engraftment in patients … MM Islami, MA Khan, MA Aseeri, MA Alshamrani, A Alnatsheh, ... Annals of Transplantation 28, e938585-1, 2023 | 3 | 2023 |
| Safety and discontinuation rate of immune checkpoint inhibitors used in patients with solid and hematological malignancies. A population based retrospective analysis A Shahbar, M Alshamrani, M Aseeri, T Alfayea, A Alnatsheh Journal of Oncology Pharmacy Practice 28 (4), 771-776, 2022 | 3 | 2022 |
| Evaluation of the use of granulocyte colony-stimulating factors (G-CSFs) for neutropenia primary prophylaxis in solid tumors at a tertiary care hospital, retrospective study AF Alshehri, A Alnatsheh, M Aseeri, T Al Fayea J Pharmacovigil 5 (248), 2, 2017 | 2 | 2017 |
| Evaluation of tyrosine kinase inhibitor discontinuation initiative in patients with chronic myeloid leukemia at princess noorah oncology center AM Noor, MA Khan, MM Al-Thomali, AH Alnatsheh, AA Absi, FM Hakami, ... Journal of Applied Hematology 13 (3), 126-131, 2022 | 1 | 2022 |
| Assessment of Cardiotoxicity incidence in patients receiving HER-2-targeted therapies for breast cancer in Saudi Arabia A Shahbar, AA Alhifany, YM Alatawi, M Alnuhait, A Alshammari, ... | | 2024 |
| The Incidence of Hematological Toxicities in Colorectal Cancer Patients Treated With Fluoropyrimidine-Based Regimens at Princess Noorah Oncology Center M Khan, S Alharbi, S Aljuhani, M Tunkar, A Morya, A Alnatsheh, ... Cureus 15 (8), 2023 | | 2023 |
| Real-World Experience of Monitoring Practice of Endocrinopathies Associated with the Use of Novel Targeted Therapies among Patients with Solid Tumors A AlHarbi, M Alshamrani, M Khan, A Alnatsheh, M Aseeri Medical Sciences 10 (4), 65, 2022 | | 2022 |
| 10 Comparing antifungal prophylaxis efficacy between fluconazole and amphotericin B lipid complex in adult patients with acute lymphocytic leukemia (ALL) receiving hyper-CVAD … AY Alamri, MA Khan, M Aseeri, A Absi, A Alnatsheh BMJ Open Quality 8 (Suppl 1), 2019 | | 2019 |
